共 4 条
[4]
Sodium-Glucose Co-transporter-2 Inhibitor of Dapagliflozin Attenuates Myocardial Ischemia/Reperfusion Injury by Limiting NLRP3 Inflammasome Activation and Modulating Autophagy
[J].
FRONTIERS IN CARDIOVASCULAR MEDICINE,
2022, 8